Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 8952 entries
Sorted by: Best Match Show Resources per page
Behaviour of different clinical, immunological and serological parameters observed in a group of HIV positive patients during a 12 month treatment period with zidovudine.

Bollettino dell'Istituto sieroterapico milanese

Crocchiolo PR, Lizioli A, Arcidiacono I, Cantaluppi P, Filippi C, Sobatti D, Bedarida G, D'Agostino F, Cambie G, Nardella ML.
PMID: 1983798
Boll Ist Sieroter Milan. 1990 Jun;69(2):423-30.

During a 12 month open clinical trial, 14 patients (6 with AIDS, 2 with ARC and 6 with PGL) were continuously administered a daily 1200 mg dose of Zidovudine. Clinical course was correlated with a number of serological (HIV...

Cite
Crocchiolo PR, Lizioli A, Arcidiacono I, et al. Behaviour of different clinical, immunological and serological parameters observed in a group of HIV positive patients during a 12 month treatment period with zidovudine. Boll Ist Sieroter Milan. 1990;69(2):423-30
Crocchiolo, P. R., Lizioli, A., Arcidiacono, I., Cantaluppi, P., Filippi, C., Sobatti, D., Bedarida, G., D'Agostino, F., Cambie, G., & Nardella, M. L. (1990). Behaviour of different clinical, immunological and serological parameters observed in a group of HIV positive patients during a 12 month treatment period with zidovudine. Bollettino dell'Istituto sieroterapico milanese, 69(2), 423-30.
Crocchiolo, P R, et al. "Behaviour of different clinical, immunological and serological parameters observed in a group of HIV positive patients during a 12 month treatment period with zidovudine." Bollettino dell'Istituto sieroterapico milanese vol. 69,2 (1990): 423-30.
Crocchiolo PR, Lizioli A, Arcidiacono I, Cantaluppi P, Filippi C, Sobatti D, Bedarida G, D'Agostino F, Cambie G, Nardella ML. Behaviour of different clinical, immunological and serological parameters observed in a group of HIV positive patients during a 12 month treatment period with zidovudine. Boll Ist Sieroter Milan. 1990 Jun;69(2):423-30. PMID: 1983798.
Copy Download .nbib Format: NLM
AIDS therapy and the detection of adverse drug effects in dental practice.

Journal of the American Dental Association (1939)

Arrowsmith JB.
PMID: 2592694
J Am Dent Assoc. 1989 Nov;46S-48S. doi: 10.14219/jada.archive.1989.0285.

No abstract available.

Cite
Arrowsmith JB. AIDS therapy and the detection of adverse drug effects in dental practice. J Am Dent Assoc. 1989;46S-48Sdoi: 10.14219/jada.archive.1989.0285.
Arrowsmith, J. B. (1989). AIDS therapy and the detection of adverse drug effects in dental practice. Journal of the American Dental Association (1939), 46S-48S. https://doi.org/10.14219/jada.archive.1989.0285
Arrowsmith, J B. "AIDS therapy and the detection of adverse drug effects in dental practice." Journal of the American Dental Association (1939) vol. (1989): 46S-48S. doi: https://doi.org/10.14219/jada.archive.1989.0285
Arrowsmith JB. AIDS therapy and the detection of adverse drug effects in dental practice. J Am Dent Assoc. 1989 Nov;46S-48S. doi: 10.14219/jada.archive.1989.0285. PMID: 2592694.
Copy Download .nbib Format: NLM
Drug information monographs for AIDS patients.

American journal of hospital pharmacy

Nabors KL, Sauer BL, Soehn MS, Flynn N.
PMID: 2773953
Am J Hosp Pharm. 1989 Aug;46(8):1546-7.

No abstract available.

Cite
Nabors KL, Sauer BL, Soehn MS, et al. Drug information monographs for AIDS patients. Am J Hosp Pharm. 1989;46(8):1546-7
Nabors, K. L., Sauer, B. L., Soehn, M. S., & Flynn, N. (1989). Drug information monographs for AIDS patients. American journal of hospital pharmacy, 46(8), 1546-7.
Nabors, K L, et al. "Drug information monographs for AIDS patients." American journal of hospital pharmacy vol. 46,8 (1989): 1546-7.
Nabors KL, Sauer BL, Soehn MS, Flynn N. Drug information monographs for AIDS patients. Am J Hosp Pharm. 1989 Aug;46(8):1546-7. PMID: 2773953.
Copy Download .nbib Format: NLM
AIDS in Edinburgh drug users: observations on the epidemic and implications for its future management.

The Journal of infection

Flegg PJ, Brettle RP.
PMID: 1673989
J Infect. 1991 Mar;22(2):113-8. doi: 10.1016/0163-4453(91)91459-b.

We are now witnessing the anticipated explosion of cases of AIDS resulting from the epidemic of HIV infection among Edinburgh drug users in the first half of the last decade. We expect the number of new cases of AIDS...

Cite
Flegg PJ, Brettle RP. AIDS in Edinburgh drug users: observations on the epidemic and implications for its future management. J Infect. 1991;22(2):113-8doi: 10.1016/0163-4453(91)91459-b.
Flegg, P. J., & Brettle, R. P. (1991). AIDS in Edinburgh drug users: observations on the epidemic and implications for its future management. The Journal of infection, 22(2), 113-8. https://doi.org/10.1016/0163-4453(91)91459-b
Flegg, P J, and Brettle, R P. "AIDS in Edinburgh drug users: observations on the epidemic and implications for its future management." The Journal of infection vol. 22,2 (1991): 113-8. doi: https://doi.org/10.1016/0163-4453(91)91459-b
Flegg PJ, Brettle RP. AIDS in Edinburgh drug users: observations on the epidemic and implications for its future management. J Infect. 1991 Mar;22(2):113-8. doi: 10.1016/0163-4453(91)91459-b. PMID: 1673989.
Copy Download .nbib Format: NLM
Targets for antiviral therapy of human immunodeficiency virus infection.

The Journal of infection

Jeffries DJ.
PMID: 2464649
J Infect. 1989 Jan;18:5-13. doi: 10.1016/s0163-4453(89)80075-1.

The development of potent anti-retroviral drugs is central to the control of human immunodeficiency virus (HIV) infection and the prevention of disease. Despite the benefit (albeit limited) shown by the early trials of zidovudine in patients with acquired immune...

Cite
Jeffries DJ. Targets for antiviral therapy of human immunodeficiency virus infection. J Infect. 1989;18:5-13doi: 10.1016/s0163-4453(89)80075-1.
Jeffries, D. J. (1989). Targets for antiviral therapy of human immunodeficiency virus infection. The Journal of infection, 185-13. https://doi.org/10.1016/s0163-4453(89)80075-1
Jeffries, D J. "Targets for antiviral therapy of human immunodeficiency virus infection." The Journal of infection vol. 18 (1989): 5-13. doi: https://doi.org/10.1016/s0163-4453(89)80075-1
Jeffries DJ. Targets for antiviral therapy of human immunodeficiency virus infection. J Infect. 1989 Jan;18:5-13. doi: 10.1016/s0163-4453(89)80075-1. PMID: 2464649.
Copy Download .nbib Format: NLM
Predictors of outcome in AIDS patients receiving zidovudine.

Journal of acquired immune deficiency syndromes

Steinberg JP, Spear JB, Murphy RL, Wallemark CB, Benson CA, Kessler HA, Pottage JC, Phair JP.
PMID: 2524583
J Acquir Immune Defic Syndr (1988). 1989;2(3):229-34.

Fifty-eight AIDS patients who previously had Pneumocystis carinii pneumonia (PCP) were enrolled in an open trial of zidovudine therapy. We analyzed baseline clinical and laboratory parameters to identify predictors of outcome. Fifty-eight patients were followed for a mean of...

Cite
Steinberg JP, Spear JB, Murphy RL, et al. Predictors of outcome in AIDS patients receiving zidovudine. J Acquir Immune Defic Syndr (1988). 1989;2(3):229-34
Steinberg, J. P., Spear, J. B., Murphy, R. L., Wallemark, C. B., Benson, C. A., Kessler, H. A., Pottage, J. C., & Phair, J. P. (1989). Predictors of outcome in AIDS patients receiving zidovudine. Journal of acquired immune deficiency syndromes, 2(3), 229-34.
Steinberg, J P, et al. "Predictors of outcome in AIDS patients receiving zidovudine." Journal of acquired immune deficiency syndromes vol. 2,3 (1989): 229-34.
Steinberg JP, Spear JB, Murphy RL, Wallemark CB, Benson CA, Kessler HA, Pottage JC, Phair JP. Predictors of outcome in AIDS patients receiving zidovudine. J Acquir Immune Defic Syndr (1988). 1989;2(3):229-34. PMID: 2524583.
Copy Download .nbib Format: NLM
[New chemical compounds with antiviral action].

Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie

Herdewijn P.
PMID: 2464877
Verh K Acad Geneeskd Belg. 1988;50(4):349-65.

No abstract available.

Cite
Herdewijn P. Nieuwe scheikundige verbindingen met antivirale werking. [New chemical compounds with antiviral action]. Verh K Acad Geneeskd Belg. 1988;50(4):349-65
Herdewijn, P. (1988). Nieuwe scheikundige verbindingen met antivirale werking. [New chemical compounds with antiviral action]. Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie, 50(4), 349-65.
Herdewijn, P. "Nieuwe scheikundige verbindingen met antivirale werking." [New chemical compounds with antiviral action]. Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie vol. 50,4 (1988): 349-65.
Herdewijn P. Nieuwe scheikundige verbindingen met antivirale werking. [New chemical compounds with antiviral action]. Verh K Acad Geneeskd Belg. 1988;50(4):349-65. Dutch. PMID: 2464877.
Copy Download .nbib Format: NLM
Erythrocytosis after zidovudine for AIDS.

Annals of internal medicine

Kennedy CA, Griffith HS, Mathisen GE.
PMID: 1984754
Ann Intern Med. 1991 Feb 01;114(3):250-1. doi: 10.7326/0003-4819-114-3-250.

No abstract available.

Cite
Kennedy CA, Griffith HS, Mathisen GE. Erythrocytosis after zidovudine for AIDS. Ann Intern Med. 1991;114(3):250-1doi: 10.7326/0003-4819-114-3-250.
Kennedy, C. A., Griffith, H. S., & Mathisen, G. E. (1991). Erythrocytosis after zidovudine for AIDS. Annals of internal medicine, 114(3), 250-1. https://doi.org/10.7326/0003-4819-114-3-250
Kennedy, C A, et al. "Erythrocytosis after zidovudine for AIDS." Annals of internal medicine vol. 114,3 (1991): 250-1. doi: https://doi.org/10.7326/0003-4819-114-3-250
Kennedy CA, Griffith HS, Mathisen GE. Erythrocytosis after zidovudine for AIDS. Ann Intern Med. 1991 Feb 01;114(3):250-1. doi: 10.7326/0003-4819-114-3-250. PMID: 1984754.
Copy Download .nbib Format: NLM
Zidovudine for children.

American family physician

[No authors listed]
PMID: 2349912
Am Fam Physician. 1990 Jun;41(6):1864, 1866.

No abstract available.

Cite
Zidovudine for children. Am Fam Physician. 1990;41(6):1864, 1866
(1990). Zidovudine for children. American family physician, 41(6), 1864, 1866.
"Zidovudine for children." American family physician vol. 41,6 (1990): 1864, 1866.
Zidovudine for children. Am Fam Physician. 1990 Jun;41(6):1864, 1866. PMID: 2349912.
Copy Download .nbib Format: NLM
[The characteristics of the opportunistic infections associated with AIDS: tuberculosis and toxoplasmosis].

Revista clinica espanola

Gatell JM.
PMID: 2236772
Rev Clin Esp. 1990 May;186(8):405-6.

No abstract available.

Cite
Gatell JM. Características de las infecciones oportunistas asociadas al SIDA: tuberculosis y toxoplasmosis. [The characteristics of the opportunistic infections associated with AIDS: tuberculosis and toxoplasmosis]. Rev Clin Esp. 1990;186(8):405-6
Gatell, J. M. (1990). Características de las infecciones oportunistas asociadas al SIDA: tuberculosis y toxoplasmosis. [The characteristics of the opportunistic infections associated with AIDS: tuberculosis and toxoplasmosis]. Revista clinica espanola, 186(8), 405-6.
Gatell, J M. "Características de las infecciones oportunistas asociadas al SIDA: tuberculosis y toxoplasmosis." [The characteristics of the opportunistic infections associated with AIDS: tuberculosis and toxoplasmosis]. Revista clinica espanola vol. 186,8 (1990): 405-6.
Gatell JM. Características de las infecciones oportunistas asociadas al SIDA: tuberculosis y toxoplasmosis. [The characteristics of the opportunistic infections associated with AIDS: tuberculosis and toxoplasmosis]. Rev Clin Esp. 1990 May;186(8):405-6. Spanish. PMID: 2236772.
Copy Download .nbib Format: NLM
Pharmacokinetics of potential anti-AIDS agents thiofoscarnet and foscarnet in the cat.

Journal of acquired immune deficiency syndromes

Straw JA, Loo TL, de Vera CC, Nelson PD, Tompkins WA, Bai SA.
PMID: 1387417
J Acquir Immune Defic Syndr (1988). 1992;5(9):936-42.

The pharmacokinetics of thiophosphonoformate (TPFA) and phosphonoformate (foscarnet, PFA) were studied in normal adult cats, a species susceptible to feline immunodeficiency virus (FIV) infection. Parent drugs and metabolites were quantitated by high-performance liquid chromatography (HPLC). TPFA had a mean...

Cite
Straw JA, Loo TL, de Vera CC, et al. Pharmacokinetics of potential anti-AIDS agents thiofoscarnet and foscarnet in the cat. J Acquir Immune Defic Syndr (1988). 1992;5(9):936-42
Straw, J. A., Loo, T. L., de Vera, C. C., Nelson, P. D., Tompkins, W. A., & Bai, S. A. (1992). Pharmacokinetics of potential anti-AIDS agents thiofoscarnet and foscarnet in the cat. Journal of acquired immune deficiency syndromes, 5(9), 936-42.
Straw, J A, et al. "Pharmacokinetics of potential anti-AIDS agents thiofoscarnet and foscarnet in the cat." Journal of acquired immune deficiency syndromes vol. 5,9 (1992): 936-42.
Straw JA, Loo TL, de Vera CC, Nelson PD, Tompkins WA, Bai SA. Pharmacokinetics of potential anti-AIDS agents thiofoscarnet and foscarnet in the cat. J Acquir Immune Defic Syndr (1988). 1992;5(9):936-42. PMID: 1387417.
Copy Download .nbib Format: NLM
Non-peptidic anti-AIDS agents: inhibition of HIV-1 proteinase by disulfonates.

Biochemical and biophysical research communications

Brinkworth RI, Fairlie DP.
PMID: 1445307
Biochem Biophys Res Commun. 1992 Oct 30;188(2):624-30. doi: 10.1016/0006-291x(92)91102-v.

Based upon an earlier observation that sodium docosanedioate (NaO2C-(CH2)20-CO2NA) weakly inhibits HIV-1 proteinase (IC50 12 microM), we have identified a class of more potent inhibitors (sulfonic acids) of this enzyme which are likewise dianionic at pH 5-6.5. Many of...

Cite
Brinkworth RI, Fairlie DP. Non-peptidic anti-AIDS agents: inhibition of HIV-1 proteinase by disulfonates. Biochem Biophys Res Commun. 1992;188(2):624-30doi: 10.1016/0006-291x(92)91102-v.
Brinkworth, R. I., & Fairlie, D. P. (1992). Non-peptidic anti-AIDS agents: inhibition of HIV-1 proteinase by disulfonates. Biochemical and biophysical research communications, 188(2), 624-30. https://doi.org/10.1016/0006-291x(92)91102-v
Brinkworth, R I, and Fairlie, D P. "Non-peptidic anti-AIDS agents: inhibition of HIV-1 proteinase by disulfonates." Biochemical and biophysical research communications vol. 188,2 (1992): 624-30. doi: https://doi.org/10.1016/0006-291x(92)91102-v
Brinkworth RI, Fairlie DP. Non-peptidic anti-AIDS agents: inhibition of HIV-1 proteinase by disulfonates. Biochem Biophys Res Commun. 1992 Oct 30;188(2):624-30. doi: 10.1016/0006-291x(92)91102-v. PMID: 1445307.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 8952 entries